Delia Snyder
About Delia Snyder
Associate Director, Quality Assurance
Delia Snyder is the Associate Director of Quality Assurance, where she contributes to maintaining and elevating the quality of investigational products. In her role, she ensures that all processes and products meet strict regulatory and quality standards, helping to deliver reliable and safe pharmaceutical solutions. Her position involves close scrutiny of protocols and systems to foster high-quality outputs, crucial for both current participants and future patient populations.
Inspiration from Edgewise's Mission
Delia Snyder finds inspiration in Edgewise's dedication to combating rare diseases, specifically Duchenne and Becker muscular dystrophy. This focus aligns with her professional goals and personal values, driving her dedication to enhancing the quality of life for affected patients. The company's commitment to these rare diseases fuels her daily drive to ensure that investigational products are both safe and effective.
Impact on Quality of Investigational Products
Each day, Delia Snyder approaches her work with the vision of positively influencing the quality of investigational products. She recognizes the importance of her role in the larger context of patient care, understanding that rigorous quality assurance today impacts both current trial participants and the broader patient community in the future. Her work contributes to the overall reliability and safety of pharmaceutical treatments.